Incidence and Predisposing Factors of Vancomycin-Induced Nephrotoxicity in Children

Infectious Diseases and Therapy

Volumn 2, Issue 1, 2013, Pages 37-46

  Ragab, Ahmed R ^a,b   Al Mazroua, Maha K ^b   Al Harony, Mona A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b Dammam Regional Poison Control Center   (Saudi Arabia)

Author keywords

Methicillin resistant Staphylococcus aureus infection; Pediatric toxicity; Renal toxicity; Vancomycin nephrotoxicity; Vancomycin therapy; Vancomycin trough level

Indexed keywords

AMINOGLYCOSIDE; CREATININE; VANCOMYCIN;

ADOLESCENT; ARTHRITIS; ARTICLE; BACTEREMIA; CHILD; CONGENITAL HEART DISEASE; DISEASE PREDISPOSITION; DRUG CLEARANCE; ENDOCARDITIS; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORBIDITY; MYOCARDITIS; NEPHROTOXICITY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RETROSPECTIVE STUDY; SKIN INFECTION;

EID: 84977086485     PISSN: 21938229     EISSN: 21936382     Source Type: Journal    
DOI: 10.1007/s40121-013-0004-8     Document Type: Article

References (15)

1. Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis. 2009;49: 65-71.
2. Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A. High dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med. 2006;166: 2138-44.
3. Ryback M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of American, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66: 82-98.
4. Geraci JE, Heilman FR, Nichols DR, Wellman WE. Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis: preliminary report. Proc Staff Meet Mayo Clin. 1958;33: 172-81.
5. Kralovicova K, Spanik S, Halko J. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients? J Chemother. 1997;9: 420-6.
6. Zimmermann AE, Katona BG, Plaisance KI. Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia. Pharmacotherapy. 1995;15: 85-91.
7. Elting LS, Rubenstein EB, Kurtin D, et al. Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice. Cancer. 1998;83: 2597-607.
8. Hermsen ED, Hanson M, Sankaranarayanan J, Stoner JA, Florescu MC, Rupp ME. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections. Expert Opin Drug Saf. 2010;9: 9-14.
9. Jeffries MN, Isakow W, Doherty JA, Micek ST, Kollef MH. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther. 2007;29: 1107-15.
10. Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least 4 grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008;52: 1330-6.
11. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med. 1993;118: 201-10.
12. American Thoracic Society. Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171: 388-416.
13. Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis. 2009;49: 507-14.
14. Rybak MJ, Albrecht LM, Boike SC, Chandrasekar PH. Nephrotoxicity of vancomycin, alone and with aminoglycoside. J Antimicrob Chemother. 1990;25: 679-87.
15. Kollef MH, Rello J, Cammarata SK. Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Med. 2004;30: 388-94.